安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- FDA Actions to Accelerate and Modernize Early and Late-Stage Clinical . . .
Learn more about actions to accelerate and modernize clinical research across the full continuum of drug development —from the Investigational New Drug (IND) phase to late-stage pivotal trials
- US FDA updates guidance to speed up drug development
The U S Food and Drug Administration said on Monday it is launching a series of measures to speed up drug research, from early-stage investigational studies to late-stage trials, under an
- FDA Actions to Accelerate and Modernize Clinical Drug Development
Today, the FDA is announcing actions to accelerate and modernize clinical research across the full continuum of drug development —from the pre-Investigational New Drug (IND) phase to late-stage pivotal trials The agency is eliminating unnecessary regulatory burden, clarifying phase-appropriate requirements and building partnerships with government, academic medical centers and the private
- FDA launches pilot program to speed up early drug trials - Yahoo
The FDA announced a series of measures Monday to accelerate drug development, including a pilot program designed to shorten the time it takes to move a drug from identification to first-in-human
- FDA launches effort to accelerate drug trials - MSN
The Food and Drug Administration on Monday announced a series of initiatives aimed at accelerating clinical trials and modernizing drug development, part of a broader effort to reduce delays in
- FDA to launch pilot program to speed up early-stage clinical trials
FDA pilot program to offer technical guidance, additional clarity on approval pathways as a way to shorten drug development time, better compete with China
- FDA moves to speed up drug development; flu shot gaps in the ED; nurse . . .
The top news stories in medicine today FDA moves to speed up drug development A new HHS initiative aims to shorten trial timelines and bring more early-stage research back to the United States The U S Food and Drug Administration (FDA) on Monday announced a series of measures meant to speed up drug development from early investigational studies through late-stage trials, part of a broader
- FDA revises master protocol guidance with new section on basket trials
The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological product development, reflecting significant stakeholder feedback it has received since the original draft was proposed Among the updates is a new section on evaluating drug effects across multiple diseases, conditions, or disease subtypes in basket trials
|
|
|